increase in the survival time of patients undergoing X-ray therapy for inoperable carcinoma of the lung has also been reported (Mitchell, 1953) . Furthermore, Mitchell (1954) has observed that after an injection of (I) into the rat, some internal organs, if dissected and treated with alkaline hydrogen peroxide, show a brilliant yellow fluorescence in ultra-violet light; the fluorescence is especially strong on the growing edge of the tumour. It seemed likely that this indicated local accumulations of 2-methyl-I:4-naphthoquinone-2: 3-oxide (II) derived from (I). Further information on possible selective concentration was therefore sought by studying the metabolism of (I) labelled with 14C in the methyl group. (Taylor and Sharpe, 1951) .
Solutions for injection.-The compound (Andrews, Marrian and Maxwell, 1956 ), which was stored as the dry dibarium salt, was dissolved in a little water containing a trace of hydrochloric acid and converted to a solution of the tetrasodium salt by percolating through a small column of Dowex 50 (sodium form). If not used at once, the solution was stored at 0°C. in a vial under nitrogen. The specific activity of the compound was determined both by plating out aliquots of known optical density (e= -5600 at 290mj/ in 0-01 N hydrochloric acid), or, after dilution with carrier material, by wet oxidation to barium carbonate which was counted and a self absorption factor applied. Both methods gave an activity of 1 83 x 105 cpm//tM. The radioactive purity of such solutions was determined before use by counting sections of a paper chromatogram of a drop of the solution run in saturated aqueous ammonium sulphate (80 vols.), 1M sodium acetate (20 vols.) and isopropanol (2 vols.). About 99 per cent of the activity was associated with the main ultraviolet absorbing spot (Rf 0.55) and the remainder with traces of slow moving material. Autoradiography of the dried paper strip and estimation of the amount of blackening of the film gave a similar result but was less convenient.
Animal experiments.-Laboratory stock albino male rats were used. The tumour bearing rats carried Walker 256 carcinoma used at the 2nd or 3rd passage from an ascites tumour. The tumour was implanted subcutaneously in the left flank some 10-days before the experiment and weighed 5-10 g. on the day of injection; animals with small, rapidly growing tumours were selected. The compound (5-10 mg.) was injected into the tail vein and the animal immediately put into a perspex metabolism chamber connected when necessary to an apparatus for collecting respired carbon dioxide in carbonate-free alkali (Mackenzie, Chandler, Keller, Cross and du Vigneaud, 1949) .
Preparation of the samples for analysis.-The animals were killed (chloroform) in a closed chamber which was later rinsed with water, and the water added to the urine sample. Immediately the animal was dead, blood was removed by cardiac puncture, the internal organs dissected, placed in weighed specimen tubes, and frozen in acetone/fCO2. The Investigation of the urine.-The total activity in the urine was determined by plating out aliquots in infinitely thin layers. Two paper chromatographic separations were run, the solvents being (a) the one referred to above and (b) n-butanol (3 vols.) and methanol (1 vol.) saturated with water containing a few drops of acetic acid.
RESULTS AND DISCUSSION
Previous studies of the metabolism of tetrasodium 2-methyl-1: 4-naphthohydroquinone diphosphate have given confused results. The fate, in rats, of intramuscular injections of the compound labelled with 32p has been studied by Neukomm (1954) and his colleagues (Neukomm, Peguiron, Lerch and Richard, 1953) who showed that exchange occurred between the compound and the inorganic phosphate pool. By extrapolation of their time curves, they deduced a curve denoting fixation and excretion of the compound and showed that the metabolism of the compound and of inorganic phosphate followed different and distinguishable courses; fixation of the compound occurred mainly in metabolically active organs and in those concerned with storage, detoxification and excretion. However, Morrison and Crowley (1952) using the same label, concluded that the phosphate groups were quickly split off and that the resulting activity was distributed as inorganic phosphate. Since injected 2-14C-methyl-1 : 4-naphthoquinone can be excreted as the hydroquinone diphosphate (Jaques, Millar and Spinks, 1954) , injection of the phosphorus labelled hydroquinone diphosphate can quickly give rise to unlabelled 2-methyl-1: 4-naphthoquinone which could then be reduced and phosphorylated by the phosphate pool to give the original injected compound with a much lower specific activity. These complications do not arise with the 14C labelled compound, and the fixation and excretion of tetrasodium 2-14C-methyl-1: 4-naphthohydroquinone diphosphate by the rat is shown in Table I . The amount associated with the blood was estimated by oxidising a known volume to carbon dioxide and assuming that the total blood volume was 6-7 ml. per 100 g. body weight (Gartland and Koch, 1928) . Only about 70 per cent of the injected radioactivity was recovered, and since the oxidation technique per hour. These maxima could infer an initial period of high intracellular concentration in the tissue and would suggest that localisation of the compound did occur to some extent. The later, steady respiration of activity shows that 2-14C-methyl-: 4-naphthoquinone is also broken down to carbon dioxide.
The products excreted in the urine by the rat were investigated by paper chromatography; results agreed with those previously reported for the metabolism of 2-14C-methyl-L: 4-naphthoquinone (Jaques, Millar and Spinks, 1954) . The methanol/butanol solvent separated 3 active components from rat urine, one having the position normally occupied by the injected compound (I). The other two (Components A and B) corresponded with the glucuronide and sulphate already described (Fig. 3 and Table II ). (Jaques, Millar and Spinks; Rickert, 1944 Rickert, , 1951 Doisy, 1949) . The ammonium sulphate system also indicated the presence of the injected material but did not separate the other active components.
The excretion of (I) even 24 hours after injection did not, of course, indicate that the compound had not undergone rapid dephosphorylation. The distribution of the intravenously injected compound in the various organs of the tumour bearing rat is shown in Table III tetrasodium-2-14C-methyl-1 : 4-naphthohydroquinone diphosphate.
Abcissa: Time in hours after injection.
Absorption Ratio (cf. Moore, Tobin and Aub, 1943) The mean BaCO3 equivalent of the whole rat was taken to be the same as for muscle. These results are given in Table IV. Tables II, III and IV show that the compound concentrates in the organs concerned with Vitamin K function and with detoxification and excretion. But, on a dry weight basis (Table IV) Ordinate: Radioactivity in cpm. Abcissa: Fraction number: (each fraction represents 2 cm. of the chromatogram). Distribution of radioactivity along a chromatogram of urine excreted by a rat bearing a Walker carcinoma during 2 hours following an injection of 5 mg. tetrasodium 2-14C-methyl-,: 4-naphthohydroquinone diphosphate (Butanol /methanol system). The three peaks of activity are, respectively, the injected compound (I), and two metabolites A and B (see Table II ).
It is probable that the figure found for the D.A.R. of the tumour is minimal since the whole tumour tissue contains more stroma than tumour cells. Since fluorescence studies indicated that nearly all the fluorescence arose from the tumour cells and not from the stroma (Mitchell, 1954) , this suggests that the actual D.A.R. in the tumour cells must be much higher than that measured for the tumour tissue as a whole.
These results add force to earlier indications that 2-14C-methyl-1: 4-naphthohydroquinone bis (disodium phosphate) can eoncentrate in tumour tissue for short periods and give hope that a compound may be developed with a similar but more pronounced radiosensitizing effect possibly acting by virtue of selective concentration in tumour tissue. The metabolism of tetrasodium 2-14C-methyl-1 : 4-naphthohydroquinone diphosphate has been studied in rats. About 30 per cent of the activity is excreted in the urine within 90 minutes of injection and activity is also found in respired carbon dioxide. Measurement of the Differential Absorption Ratio of various internal organs shows that, for short periods after injection, the compound concentrates more in tumour tissue than in muscle, but that it also accumulates in organs concerned with detoxification, excretion and Vitamin K function.
